Treeline Biosciences Stock
HealthTechLooking to sell Treeline Biosciences stock or options?
Treeline Biosciences is engaged in creating cutting-edge precision medicines aimed at treating cancer and other severe ailments. The company's platform leverages insights into normal and diseased biological processes, experimental data, genomics, and pattern recognition to craft breakthrough treatments that address unmet patient needs, empowering healthcare providers to effectively combat cancer and other critical conditions.
Notable investors include:
Other investors include:
Casdin Capital, OrbiMed, Aisling Capital, Kohlberg Kravis Roberts, Exor, Fidelity, Zeus Health, Access Industries, Ajax Health, Arc Ventures (United States).